Tokyo Tape
Sign in
← Terumo

Quarterly report · Q1

4543.TEDINET S100RML8
Period2023-04-01 → 2023-06-30
Filed2023-08-10
StandardIFRS
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 47
MetricValuePeriodScopeSource row
Revenue¥215.3bn2023-04-01 → 2023-06-30Cons.Revenue IFRS
Revenue¥820.2bn2022-04-01 → 2023-03-31Cons.Revenue IFRS (5-year summary)
Revenue¥197.3bn2022-04-01 → 2022-06-30Cons.Revenue IFRS
Operating income¥29.6bn2023-04-01 → 2023-06-30Cons.Operating profit loss IFRS
Operating income¥30.4bn2022-04-01 → 2022-06-30Cons.Operating profit loss IFRS
Profit before tax¥29.8bn2023-04-01 → 2023-06-30Cons.Profit loss before tax IFRS
Profit before tax¥116.1bn2022-04-01 → 2023-03-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥29.7bn2022-04-01 → 2022-06-30Cons.Profit loss before tax IFRS
Net income (owners)¥22.5bn2023-04-01 → 2023-06-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥89.3bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥22.4bn2022-04-01 → 2022-06-30Cons.Profit loss attributable to owners of parent IFRS
Net income¥22.5bn2023-04-01 → 2023-06-30Cons.Profit loss IFRS
Net income¥22.4bn2022-04-01 → 2022-06-30Cons.Profit loss IFRS
Total assets¥1.67Tat 2023-06-30Cons.Assets IFRS
Total assets¥1.60Tat 2023-03-31Cons.Assets IFRS
Total assets¥1.58Tat 2022-06-30Cons.Total assets IFRS (5-year summary)
Total liabilities¥468.1bnat 2023-06-30Cons.Liabilities IFRS
Total liabilities¥491.2bnat 2023-03-31Cons.Liabilities IFRS
Net assets / equity¥1.20Tat 2023-06-30Cons.Equity IFRS
Net assets / equity¥1.11Tat 2023-03-31Cons.Equity IFRS
Net assets / equity¥1.12Tat 2022-06-30Cons.Equity IFRS
Net assets / equity¥1.01Tat 2022-03-31dCons.Equity IFRS
Equity (owners)¥1.20Tat 2023-06-30Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥1.11Tat 2023-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥1.12Tat 2022-06-30Cons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥160.1bnat 2023-06-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥187.3bnat 2023-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥209.6bnat 2022-06-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥205.3bnat 2022-03-31dCons.Cash and cash equivalents IFRS
Operating cash flow¥11.4bn2023-04-01 → 2023-06-30Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥117.5bn2022-04-01 → 2023-03-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥23.4bn2022-04-01 → 2022-06-30Cons.Net cash provided by used in operating activities IFRS
Investing cash flow−¥19.3bn2023-04-01 → 2023-06-30Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥59.1bn2022-04-01 → 2023-03-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥16.1bn2022-04-01 → 2022-06-30Cons.Net cash provided by used in investing activities IFRS
Financing cash flow−¥27.5bn2023-04-01 → 2023-06-30Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥86.6bn2022-04-01 → 2023-03-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥14.8bn2022-04-01 → 2022-06-30Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥30.282023-04-01 → 2023-06-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥1192022-04-01 → 2023-03-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥29.612022-04-01 → 2022-06-30Cons.Basic earnings loss per share IFRS
EPS (diluted)¥30.272023-04-01 → 2023-06-30Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥118.952022-04-01 → 2023-03-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥29.62022-04-01 → 2022-06-30Cons.Diluted earnings loss per share IFRS
Equity ratio72.0%at 2023-06-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio69.3%at 2023-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio70.5%at 2022-06-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 20
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue external2023-04-01 → 2023-06-30¥62m
Reconciling Itemsreconcilingsegment profit2023-04-01 → 2023-06-30−¥1.1bn
jpcrp040300-q1r_E01630-000Blood And Cell Technologies Companyreportable segmentrevenue external2023-04-01 → 2023-06-30¥40.9bn
jpcrp040300-q1r_E01630-000Blood And Cell Technologies Companyreportable segmentsegment profit2023-04-01 → 2023-06-30¥5.9bn
jpcrp040300-q1r_E01630-000Cardiac And Vascular Companyreportable segmentrevenue external2023-04-01 → 2023-06-30¥130.6bn
jpcrp040300-q1r_E01630-000Cardiac And Vascular Companyreportable segmentsegment profit2023-04-01 → 2023-06-30¥26.9bn
jpcrp040300-q1r_E01630-000Medical Care Solutions Companyreportable segmentrevenue external2023-04-01 → 2023-06-30¥43.7bn
jpcrp040300-q1r_E01630-000Medical Care Solutions Companyreportable segmentsegment profit2023-04-01 → 2023-06-30¥2.8bn
—segment totalrevenue external2023-04-01 → 2023-06-30¥215.2bn
—segment totalsegment profit2023-04-01 → 2023-06-30¥35.6bn
Reconciling Itemsreconcilingrevenue external2022-04-01 → 2022-06-30¥62m
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-06-30−¥198m
jpcrp040300-q1r_E01630-000Blood And Cell Technologies Companyreportable segmentrevenue external2022-04-01 → 2022-06-30¥34.5bn
jpcrp040300-q1r_E01630-000Blood And Cell Technologies Companyreportable segmentsegment profit2022-04-01 → 2022-06-30¥3.6bn
jpcrp040300-q1r_E01630-000Cardiac And Vascular Companyreportable segmentrevenue external2022-04-01 → 2022-06-30¥116.8bn
jpcrp040300-q1r_E01630-000Cardiac And Vascular Companyreportable segmentsegment profit2022-04-01 → 2022-06-30¥28.0bn
jpcrp040300-q1r_E01630-000Medical Care Solutions Companyreportable segmentrevenue external2022-04-01 → 2022-06-30¥46.0bn
jpcrp040300-q1r_E01630-000Medical Care Solutions Companyreportable segmentsegment profit2022-04-01 → 2022-06-30¥4.5bn
—segment totalrevenue external2022-04-01 → 2022-06-30¥197.3bn
—segment totalsegment profit2022-04-01 → 2022-06-30¥36.1bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 561
ItemContextValueUnit
Revenue from external customers IFRSCurrentYTDDuration_jpcrp040300-q1r_E01630-000MedicalCareSolutionsCompanyReportableSegmentMember43681000000JPY
Revenue from external customers IFRSCurrentYTDDuration_jpcrp040300-q1r_E01630-000BloodAndCellTechnologiesCompanyReportableSegmentMember40924000000JPY
Revenue from external customers IFRSCurrentYTDDuration_ReportableSegmentsMember215190000000JPY
Revenue from external customers IFRSCurrentYTDDuration_ReconcilingItemsMember62000000JPY
Revenue from external customers IFRSCurrentYTDDuration215252000000JPY
Segment profit loss IFRSCurrentYTDDuration_jpcrp040300-q1r_E01630-000CardiacAndVascularCompanyReportableSegmentMember26883000000JPY
Segment profit loss IFRSCurrentYTDDuration_jpcrp040300-q1r_E01630-000MedicalCareSolutionsCompanyReportableSegmentMember2814000000JPY
Segment profit loss IFRSCurrentYTDDuration_jpcrp040300-q1r_E01630-000BloodAndCellTechnologiesCompanyReportableSegmentMember5857000000JPY
Segment profit loss IFRSCurrentYTDDuration_ReportableSegmentsMember35554000000JPY
Segment profit loss IFRSCurrentYTDDuration_ReconcilingItemsMember-1076000000JPY
Segment profit loss IFRSCurrentYTDDuration34478000000JPY
Amortization of intangible assets acquired through business combinations IFRSCurrentYTDDuration_jpcrp040300-q1r_E01630-000CardiacAndVascularCompanyReportableSegmentMember-2224000000JPY
Amortization of intangible assets acquired through business combinations IFRSCurrentYTDDuration_jpcrp040300-q1r_E01630-000MedicalCareSolutionsCompanyReportableSegmentMember－JPY
Amortization of intangible assets acquired through business combinations IFRSCurrentYTDDuration_jpcrp040300-q1r_E01630-000BloodAndCellTechnologiesCompanyReportableSegmentMember-2529000000JPY
Amortization of intangible assets acquired through business combinations IFRSCurrentYTDDuration_ReportableSegmentsMember-4754000000JPY
Amortization of intangible assets acquired through business combinations IFRSCurrentYTDDuration_ReconcilingItemsMember138000000JPY
Amortization of intangible assets acquired through business combinations IFRSCurrentYTDDuration-4615000000JPY
Non recurring profit or loss IFRSCurrentYTDDuration-218000000JPY
Operating profit loss IFRSCurrentYTDDuration29644000000JPY
Finance income IFRSCurrentYTDDuration593000000JPY
Finance costs IFRSCurrentYTDDuration444000000JPY
Share of profit loss of investments accounted for using equity method IFRSCurrentYTDDuration11000000JPY
Profit loss before tax IFRSCurrentYTDDuration29804000000JPY
Document title cover pageFilingDateInstant
Original text (Japanese)四半期報告書
Clause of stipulation cover pageFilingDateInstant
Original text (Japanese)金融商品取引法第24条の４の７第１項
Place of filing cover pageFilingDateInstant
Original text (Japanese)関東財務局長
Filing date cover pageFilingDateInstant2023-08-10
Quarterly accounting period cover pageFilingDateInstant
Original text (Japanese)第109期第１四半期(自　2023年４月１日　至　2023年６月30日)
Company name cover pageFilingDateInstant
Original text (Japanese)テルモ株式会社
Company name in english cover pageFilingDateInstantTERUMO CORPORATION
Title and name of representative cover pageFilingDateInstant
Original text (Japanese)代表取締役社長CEO　佐藤　慎次郎
Address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)東京都渋谷区幡ケ谷二丁目44番１号
Telephone number address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)03(3374)8111(代表)
Name of contact person address of registered headquarter cover pageFilingDateInstantText · Plus
Nearest place of contact cover pageFilingDateInstant
Original text (Japanese)東京都新宿区西新宿三丁目20番２号 東京オペラシティタワー 49F
Telephone number nearest place of contact cover pageFilingDateInstant
Original text (Japanese)03(6742)8500(代表)
Name of contact person nearest place of contact cover pageFilingDateInstantText · Plus
Place for public inspection cover page (text)FilingDateInstantText · Plus
Edinet codeFilingDateInstantE01630
Fund codeFilingDateInstant－
Security codeFilingDateInstant45430
Filer name in japaneseFilingDateInstant
Original text (Japanese)テルモ株式会社
Filer name in englishFilingDateInstantTERUMO CORPORATION
Fund name in japaneseFilingDateInstant－
Fund name in englishFilingDateInstant－
Cabinet office ordinanceFilingDateInstant
Original text (Japanese)企業内容等の開示に関する内閣府令
Document typeFilingDateInstant
Original text (Japanese)第四号の三様式
Accounting standardsFilingDateInstantIFRS
Whether consolidated financial statements are preparedFilingDateInstanttrue
Industry code when consolidated financial statements are prepared in accordance with industry specific regulationsFilingDateInstantcte

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-03-31pass
balance sheet identityconsolidated 2023-06-30pass rounding
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-06-30pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-06-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-06-30pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2023-06-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-06-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-06-30pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-06-30pass